← All stocks

Corvus Pharmaceuticals, Inc.

CRVS Net buying
CIK 0001626971 #2415 in the set updated 18 Sep 2026
Bought (12 mo)
$333.69K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$333.69K
+$333.69K against sales at will

By person

5 insiders · 16 transactions

There is no salary here to measure against. Corvus Pharmaceuticals, Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Moore David Scott
Director
$250.24K (1)
+$250.24K
21,700
0.0258%
$250.24K
MILLER RICHARD A MD
President and CEO
$83.45K (2)
+$83.45K
2,331,742
2.77%
$26.89M
+32.1%
Thompson Peter A.
Director
7,375,006
8.77%
$85.05M
+6.2%
ORBIMED ADVISORS LLC entity
Director
7,165,006
8.52%
$82.62M
+3.2%
Jones William Benton
See Remarks
173,130
0.2058%
$2.00M
+12.6%
Insider
Date
Role
Action
Shares
Price
Amount
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$2.12
$31.80K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$1.64
$24.60K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$2.49
$37.35K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$0.97
$14.48K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$0.99
$14.85K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$2.60
$39.00K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$2.74
$41.10K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$3.27
$49.05K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$2.00
$30.00K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$3.61
$54.15K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$12.50
$187.50K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
15,000
$9.70
$145.50K
Thompson Peter A.
28 Jan 2026
Director
Exercised, kept
30,000
$15.00
$450.00K

What was left out

Form 4 filings counted 13
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 210,000
History held since 8 Dec 2016